Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVLA | CRVS | IOVA | ||
| Company | Palvella Therapeutics Inc | Corvus Pharma Com | Iovance Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 140.28 | 18.13 | 3.82 | ||
| High | 151.18 | 18.46 | 3.84 | ||
| Low | 137.00 | 17.89 | 3.50 | ||
| Latest | 148.34 | 18.26 | 3.79 | ||
| Change | +19.74 | +0.06 | -0.04 | ||
| % Change | +15.35% | +0.33% | -1.04% | ||
| Volume | 1,230,714 | 1,038,415 | 22,329,923 | ||
| 20-Day Average Volume | 406,223 | 1,544,180 | 14,460,829 | ||
| Previous Close | 128.60 | 18.20 | 3.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 88.79 | 19.13 | 2.80 | ||
| 20-Day Raw Stochastic | 99.24% | 32.53% | 73.34% | ||
| 20-Day Relative Strength | 76.32 | 56.05 | 72.61 | ||
| Weighted Alpha | +346.58 | +48.83 | +39.89 | ||
| Today's Opinion | 88% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 72% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +82.90% since 02/19/26 | +3.54% since 02/19/26 | +32.99% since 02/19/26 | ||
| Low | 78.17 on 02/20/26 | 16.13 on 02/20/26 | 2.75 on 02/20/26 | ||
| High | 151.18 on 02/26/26 | 18.45 on 02/26/26 | 4.35 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | +73.12% since 01/26/26 | -21.12% since 01/26/26 | +31.15% since 01/26/26 | ||
| Low | 72.22 on 01/30/26 | 16.13 on 02/20/26 | 2.25 on 02/05/26 | ||
| High | 151.18 on 02/26/26 | 23.51 on 01/27/26 | 4.35 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +50.60% since 11/26/25 | +100.11% since 11/26/25 | +55.33% since 11/26/25 | ||
| Low | 72.22 on 01/30/26 | 6.39 on 01/12/26 | 2.08 on 12/16/25 | ||
| High | 151.18 on 02/26/26 | 26.95 on 01/23/26 | 4.35 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +180.12% since 08/26/25 | +227.62% since 08/26/25 | +54.70% since 08/26/25 | ||
| Low | 49.81 on 08/29/25 | 5.28 on 08/28/25 | 1.76 on 11/05/25 | ||
| High | 151.18 on 02/26/26 | 26.95 on 01/23/26 | 4.35 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,522,110 | 1,524,578 | 1,520,387 | ||
| Shares Outstanding, K | 11,836 | 83,768 | 396,968 | ||
| Annual Sales | 0 | 0 | 164,070,000 | ||
| Annual Net Income | -17,430,000 | -62,290,000 | -372,180,000 | ||
| Last Quarter Sales | 0 | 0 | 67,460,000 | ||
| Last Quarter Net Income | -11,350,000 | -10,160,000 | -91,250,000 | ||
| 60-Month Beta | -0.16 | 0.73 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/11/25 | -0.12 on 11/04/25 | -0.25 on 11/06/25 | ||
| Latest Earnings Date | 03/30/26 | 03/24/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||